Most salivary gland tumors are benign and occur in the parotid glands. A painless salivary mass is the most common sign and is evaluated by fine-needle aspiration biopsy. Imaging with CT and MRI can be helpful. For malignant tumors, treatment is with excision and radiation. Long-term results are related to the grade of the cancer.
About 85% of salivary gland tumors occur in the parotid glands, followed by the submandibular and minor salivary glands, and about 1% occur in the sublingual glands. About 75 to 80% are benign, slow-growing, movable, painless, usually solitary nodules beneath normal skin or mucosa. Occasionally, when cystic, they are soft but most often they are firm.
The most common type is a pleomorphic adenoma (mixed tumor). Malignant transformation is possible, resulting in carcinoma ex mixed tumor, but this usually occurs only after the benign tumor has been present for 15 to 20 yr. If malignant transformation occurs, the cure rates are very low, despite adequate surgery and adjuvant therapy.
Other benign tumors include monomorphic adenoma, oncocytoma, and papillary cystadenoma lymphomatosum (previously known as cylindroma). These tumors rarely recur and rarely become malignant.
Malignant salivary gland tumors:
Malignant tumors are less common and are characterized by rapid growth or a sudden growth spurt. They are firm, nodular, and can be fixed to adjacent tissue, often with a poorly defined periphery. Pain and neural involvement are common. Eventually, the overlying skin or mucosa may become ulcerated or the adjacent tissues may become invaded. Surgery, followed by radiation therapy, is the treatment of choice for resectable disease. Currently, there is no effective chemotherapy for salivary cancer.
Mucoepidermoid carcinoma is the most common salivary gland cancer, typically occurring in people in their 20s to 50s. It can manifest in any salivary gland, often in a minor salivary gland of the palate, or it can occur deep within the bone, such as in the wall of a dentigerous cyst. Intermediate and high-grade mucoepidermoid carcinomas may metastasize to the regional lymphatics, which must be addressed with surgical dissection or postoperative radiation therapy.
Adenoid cystic carcinoma is the most common malignant tumor of minor salivary glands (and of the trachea). It is a slowly growing malignant transformation of a much more common benign cylindroma. Its peak incidence is between ages 40 and 60, and symptoms include severe pain and, often, facial nerve paralysis. It has a propensity for perineural invasion and spread, with disease potentially extending many centimeters from the main tumor mass. Lymphatic spread is not a common feature of this tumor, so elective nodal treatment is less common. Although the 5- and 10-yr survival rates are quite good, the 15- and 20-yr rates are quite poor, with most patients developing distant metastases. Pulmonary metastases are common, although patients can live quite long with them.
Acinic cell carcinoma, a common parotid tumor, occurs in people in their 40s and 50s. This carcinoma has a more indolent course, as well as an incidence of multifocality.
Carcinoma ex mixed tumor is adenocarcinoma arising in a preexisting benign carcinoma ex mixed tumor. Only the carcinomatous element metastasizes.
Symptoms and Signs
Most benign and malignant tumors manifest as a painless mass. However, malignant tumors may invade nerves, causing localized or regional pain, numbness, paresthesia, causalgia, or a loss of motor function.
CT and MRI locate the tumor and describe its extent. Biopsy confirms the cell type. A search for spread to regional nodes or distant metastases in the lung, liver, bone, or brain may be indicated before treatment is selected.
Treatment of benign tumors is surgery. The recurrence rate is high when excision is incomplete.
Treatment of mucoepidermoid carcinoma consists of wide excision and postoperative radiation. The 5-yr survival rate is 95% with the low-grade type, primarily affecting mucus cells, and 50% with the high-grade type, primarily affecting epidermoid cells. Treatment of adenoid cystic carcinoma is wide surgical excision, but local recurrence is common. Lung metastases and death are likely, although many years, to a decade or more, after the initial diagnosis and treatment. The prognosis for acinic cell carcinoma is favorable after wide excision. All surgeries are designed to spare the facial nerve, which is sacrificed only in cases of direct tumor involvement with the nerve.
Last full review/revision July 2008 by Richard V. Smith, MD
Content last modified September 2010